 | • レポートコード：MRC2-11QY07244 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はリポソームのグローバル市場について調査・分析したレポートです。種類別（リポソームドキソルビシン、リポソームアンホテラシンB、リポソームパクリタキセル、その他）市場規模、用途別（真菌感染症治療、がん・腫瘍治療、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別リポソームの競争状況、市場シェア ・世界のリポソーム市場：種類別市場規模 2015年-2020年（リポソームドキソルビシン、リポソームアンホテラシンB、リポソームパクリタキセル、その他） ・世界のリポソーム市場：種類別市場規模予測 2021年-2026年（リポソームドキソルビシン、リポソームアンホテラシンB、リポソームパクリタキセル、その他） ・世界のリポソーム市場：用途別市場規模 2015年-2020年（真菌感染症治療、がん・腫瘍治療、その他） ・世界のリポソーム市場：用途別市場規模予測 2021年-2026年（真菌感染症治療、がん・腫瘍治療、その他） ・北米のリポソーム市場分析：米国、カナダ ・ヨーロッパのリポソーム市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのリポソーム市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のリポソーム市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのリポソーム市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Johnson & Johnson、Gilead Sciences、Pacira、Sun Pharmaceutical、Luye Pharma、Sigma-Tau Group、Fudan-Zhangjiang、Teva Pharmaceutical、CSPC、Novartis、Kingond Pharm、Spectrum Pharmaceuticals、Shanghai New Asia ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Liposomes are spherical nano-sized bilayered vesicles or “bags” in which an aqueous volume is entirely closed within a membrane composed of lipid (fat) molecules, usually phospholipids. The components within the bilayer define the rigidity/ fluidity and charge of the bilayer.
North America dominated the market with market share of 44.2% due to the high medical level. Following North America, Europe is the second largest market with market share of 36%. Asian Pacific regions are the third largest market with developed countries like Japan and many developing countries like China. Its market share is about 12.85%.
Market Analysis and Insights: Global Liposomes Market
The global Liposomes market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Liposomes Scope and Market Size
Liposomes market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Liposomes market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Liposomes market is segmented into
Liposomal Doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Other
Segment by Application, the Liposomes market is segmented into
Fungal Infection Therapy
Cancer & Tumor Therapy
Other
Regional and Country-level Analysis
The Liposomes market is analysed and market size information is provided by regions (countries).
The key regions covered in the Liposomes market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Liposomes Market Share Analysis
Liposomes market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Liposomes business, the date to enter into the Liposomes market, Liposomes product introduction, recent developments, etc.
The major vendors covered:
Johnson & Johnson
Gilead Sciences
Pacira
Sun Pharmaceutical
Luye Pharma
Sigma-Tau Group
Fudan-Zhangjiang
Teva Pharmaceutical
CSPC
Novartis
Kingond Pharm
Spectrum Pharmaceuticals
Shanghai New Asia
1 Study Coverage
1.1 Liposomes Product Introduction
1.2 Market Segments
1.3 Key Liposomes Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Liposomes Market Size Growth Rate by Type
1.4.2 Liposomal Doxorubicin
1.4.3 Liposomal Amphoteracin B
1.4.4 Liposomal Paclitaxel
1.4.5 Other
1.5 Market by Application
1.5.1 Global Liposomes Market Size Growth Rate by Application
1.5.2 Fungal Infection Therapy
1.5.3 Cancer & Tumor Therapy
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Liposomes Market Size, Estimates and Forecasts
2.1.1 Global Liposomes Revenue 2015-2026
2.1.2 Global Liposomes Sales 2015-2026
2.2 Global Liposomes, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Liposomes Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Liposomes Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Liposomes Competitor Landscape by Players
3.1 Liposomes Sales by Manufacturers
3.1.1 Liposomes Sales by Manufacturers (2015-2020)
3.1.2 Liposomes Sales Market Share by Manufacturers (2015-2020)
3.2 Liposomes Revenue by Manufacturers
3.2.1 Liposomes Revenue by Manufacturers (2015-2020)
3.2.2 Liposomes Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Liposomes Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Liposomes Revenue in 2019
3.2.5 Global Liposomes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Liposomes Price by Manufacturers
3.4 Liposomes Manufacturing Base Distribution, Product Types
3.4.1 Liposomes Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Liposomes Product Type
3.4.3 Date of International Manufacturers Enter into Liposomes Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Liposomes Market Size by Type (2015-2020)
4.1.1 Global Liposomes Sales by Type (2015-2020)
4.1.2 Global Liposomes Revenue by Type (2015-2020)
4.1.3 Liposomes Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Liposomes Market Size Forecast by Type (2021-2026)
4.2.1 Global Liposomes Sales Forecast by Type (2021-2026)
4.2.2 Global Liposomes Revenue Forecast by Type (2021-2026)
4.2.3 Liposomes Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Liposomes Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Liposomes Market Size by Application (2015-2020)
5.1.1 Global Liposomes Sales by Application (2015-2020)
5.1.2 Global Liposomes Revenue by Application (2015-2020)
5.1.3 Liposomes Price by Application (2015-2020)
5.2 Liposomes Market Size Forecast by Application (2021-2026)
5.2.1 Global Liposomes Sales Forecast by Application (2021-2026)
5.2.2 Global Liposomes Revenue Forecast by Application (2021-2026)
5.2.3 Global Liposomes Price Forecast by Application (2021-2026)
6 North America
6.1 North America Liposomes by Country
6.1.1 North America Liposomes Sales by Country
6.1.2 North America Liposomes Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Liposomes Market Facts & Figures by Type
6.3 North America Liposomes Market Facts & Figures by Application
7 Europe
7.1 Europe Liposomes by Country
7.1.1 Europe Liposomes Sales by Country
7.1.2 Europe Liposomes Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Liposomes Market Facts & Figures by Type
7.3 Europe Liposomes Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Liposomes by Region
8.1.1 Asia Pacific Liposomes Sales by Region
8.1.2 Asia Pacific Liposomes Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Liposomes Market Facts & Figures by Type
8.3 Asia Pacific Liposomes Market Facts & Figures by Application
9 Latin America
9.1 Latin America Liposomes by Country
9.1.1 Latin America Liposomes Sales by Country
9.1.2 Latin America Liposomes Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Liposomes Market Facts & Figures by Type
9.3 Central & South America Liposomes Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Liposomes by Country
10.1.1 Middle East and Africa Liposomes Sales by Country
10.1.2 Middle East and Africa Liposomes Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Liposomes Market Facts & Figures by Type
10.3 Middle East and Africa Liposomes Market Facts & Figures by Application
11 Company Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Corporation Information
11.1.2 Johnson & Johnson Description and Business Overview
11.1.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Johnson & Johnson Liposomes Products Offered
11.1.5 Johnson & Johnson Related Developments
11.2 Gilead Sciences
11.2.1 Gilead Sciences Corporation Information
11.2.2 Gilead Sciences Description and Business Overview
11.2.3 Gilead Sciences Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Gilead Sciences Liposomes Products Offered
11.2.5 Gilead Sciences Related Developments
11.3 Pacira
11.3.1 Pacira Corporation Information
11.3.2 Pacira Description and Business Overview
11.3.3 Pacira Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Pacira Liposomes Products Offered
11.3.5 Pacira Related Developments
11.4 Sun Pharmaceutical
11.4.1 Sun Pharmaceutical Corporation Information
11.4.2 Sun Pharmaceutical Description and Business Overview
11.4.3 Sun Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Sun Pharmaceutical Liposomes Products Offered
11.4.5 Sun Pharmaceutical Related Developments
11.5 Luye Pharma
11.5.1 Luye Pharma Corporation Information
11.5.2 Luye Pharma Description and Business Overview
11.5.3 Luye Pharma Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Luye Pharma Liposomes Products Offered
11.5.5 Luye Pharma Related Developments
11.6 Sigma-Tau Group
11.6.1 Sigma-Tau Group Corporation Information
11.6.2 Sigma-Tau Group Description and Business Overview
11.6.3 Sigma-Tau Group Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Sigma-Tau Group Liposomes Products Offered
11.6.5 Sigma-Tau Group Related Developments
11.7 Fudan-Zhangjiang
11.7.1 Fudan-Zhangjiang Corporation Information
11.7.2 Fudan-Zhangjiang Description and Business Overview
11.7.3 Fudan-Zhangjiang Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Fudan-Zhangjiang Liposomes Products Offered
11.7.5 Fudan-Zhangjiang Related Developments
11.8 Teva Pharmaceutical
11.8.1 Teva Pharmaceutical Corporation Information
11.8.2 Teva Pharmaceutical Description and Business Overview
11.8.3 Teva Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Teva Pharmaceutical Liposomes Products Offered
11.8.5 Teva Pharmaceutical Related Developments
11.9 CSPC
11.9.1 CSPC Corporation Information
11.9.2 CSPC Description and Business Overview
11.9.3 CSPC Sales, Revenue and Gross Margin (2015-2020)
11.9.4 CSPC Liposomes Products Offered
11.9.5 CSPC Related Developments
11.10 Novartis
11.10.1 Novartis Corporation Information
11.10.2 Novartis Description and Business Overview
11.10.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Novartis Liposomes Products Offered
11.10.5 Novartis Related Developments
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Corporation Information
11.1.2 Johnson & Johnson Description and Business Overview
11.1.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Johnson & Johnson Liposomes Products Offered
11.1.5 Johnson & Johnson Related Developments
11.12 Spectrum Pharmaceuticals
11.12.1 Spectrum Pharmaceuticals Corporation Information
11.12.2 Spectrum Pharmaceuticals Description and Business Overview
11.12.3 Spectrum Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Spectrum Pharmaceuticals Products Offered
11.12.5 Spectrum Pharmaceuticals Related Developments
11.13 Shanghai New Asia
11.13.1 Shanghai New Asia Corporation Information
11.13.2 Shanghai New Asia Description and Business Overview
11.13.3 Shanghai New Asia Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Shanghai New Asia Products Offered
11.13.5 Shanghai New Asia Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Liposomes Market Estimates and Projections by Region
12.1.1 Global Liposomes Sales Forecast by Regions 2021-2026
12.1.2 Global Liposomes Revenue Forecast by Regions 2021-2026
12.2 North America Liposomes Market Size Forecast (2021-2026)
12.2.1 North America: Liposomes Sales Forecast (2021-2026)
12.2.2 North America: Liposomes Revenue Forecast (2021-2026)
12.2.3 North America: Liposomes Market Size Forecast by Country (2021-2026)
12.3 Europe Liposomes Market Size Forecast (2021-2026)
12.3.1 Europe: Liposomes Sales Forecast (2021-2026)
12.3.2 Europe: Liposomes Revenue Forecast (2021-2026)
12.3.3 Europe: Liposomes Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Liposomes Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Liposomes Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Liposomes Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Liposomes Market Size Forecast by Region (2021-2026)
12.5 Latin America Liposomes Market Size Forecast (2021-2026)
12.5.1 Latin America: Liposomes Sales Forecast (2021-2026)
12.5.2 Latin America: Liposomes Revenue Forecast (2021-2026)
12.5.3 Latin America: Liposomes Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Liposomes Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Liposomes Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Liposomes Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Liposomes Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Liposomes Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Liposomes Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Liposomes Market Segments
Table 2. Ranking of Global Top Liposomes Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Liposomes Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Liposomal Doxorubicin
Table 5. Major Manufacturers of Liposomal Amphoteracin B
Table 6. Major Manufacturers of Liposomal Paclitaxel
Table 7. Major Manufacturers of Other
Table 8. Global Liposomes Market Size Growth Rate by Application 2020-2026 (K Units)
Table 9. Global Liposomes Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 10. Global Liposomes Sales by Regions 2015-2020 (K Units)
Table 11. Global Liposomes Sales Market Share by Regions (2015-2020)
Table 12. Global Liposomes Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Liposomes Sales by Manufacturers (2015-2020) (K Units)
Table 14. Global Liposomes Sales Share by Manufacturers (2015-2020)
Table 15. Global Liposomes Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Liposomes by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liposomes as of 2019)
Table 17. Liposomes Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Liposomes Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Liposomes Price (2015-2020) (USD/Unit)
Table 20. Liposomes Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Liposomes Product Type
Table 22. Date of International Manufacturers Enter into Liposomes Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Liposomes Sales by Type (2015-2020) (K Units)
Table 25. Global Liposomes Sales Share by Type (2015-2020)
Table 26. Global Liposomes Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Liposomes Revenue Share by Type (2015-2020)
Table 28. Liposomes Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 29. Global Liposomes Sales by Application (2015-2020) (K Units)
Table 30. Global Liposomes Sales Share by Application (2015-2020)
Table 31. North America Liposomes Sales by Country (2015-2020) (K Units)
Table 32. North America Liposomes Sales Market Share by Country (2015-2020)
Table 33. North America Liposomes Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Liposomes Revenue Market Share by Country (2015-2020)
Table 35. North America Liposomes Sales by Type (2015-2020) (K Units)
Table 36. North America Liposomes Sales Market Share by Type (2015-2020)
Table 37. North America Liposomes Sales by Application (2015-2020) (K Units)
Table 38. North America Liposomes Sales Market Share by Application (2015-2020)
Table 39. Europe Liposomes Sales by Country (2015-2020) (K Units)
Table 40. Europe Liposomes Sales Market Share by Country (2015-2020)
Table 41. Europe Liposomes Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Liposomes Revenue Market Share by Country (2015-2020)
Table 43. Europe Liposomes Sales by Type (2015-2020) (K Units)
Table 44. Europe Liposomes Sales Market Share by Type (2015-2020)
Table 45. Europe Liposomes Sales by Application (2015-2020) (K Units)
Table 46. Europe Liposomes Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Liposomes Sales by Region (2015-2020) (K Units)
Table 48. Asia Pacific Liposomes Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Liposomes Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Liposomes Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Liposomes Sales by Type (2015-2020) (K Units)
Table 52. Asia Pacific Liposomes Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Liposomes Sales by Application (2015-2020) (K Units)
Table 54. Asia Pacific Liposomes Sales Market Share by Application (2015-2020)
Table 55. Latin America Liposomes Sales by Country (2015-2020) (K Units)
Table 56. Latin America Liposomes Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Liposomes Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Liposomes Revenue Market Share by Country (2015-2020)
Table 59. Latin America Liposomes Sales by Type (2015-2020) (K Units)
Table 60. Latin America Liposomes Sales Market Share by Type (2015-2020)
Table 61. Latin America Liposomes Sales by Application (2015-2020) (K Units)
Table 62. Latin America Liposomes Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Liposomes Sales by Country (2015-2020) (K Units)
Table 64. Middle East and Africa Liposomes Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Liposomes Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Liposomes Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Liposomes Sales by Type (2015-2020) (K Units)
Table 68. Middle East and Africa Liposomes Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Liposomes Sales by Application (2015-2020) (K Units)
Table 70. Middle East and Africa Liposomes Sales Market Share by Application (2015-2020)
Table 71. Johnson & Johnson Corporation Information
Table 72. Johnson & Johnson Description and Major Businesses
Table 73. Johnson & Johnson Liposomes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 74. Johnson & Johnson Product
Table 75. Johnson & Johnson Recent Development
Table 76. Gilead Sciences Corporation Information
Table 77. Gilead Sciences Description and Major Businesses
Table 78. Gilead Sciences Liposomes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 79. Gilead Sciences Product
Table 80. Gilead Sciences Recent Development
Table 81. Pacira Corporation Information
Table 82. Pacira Description and Major Businesses
Table 83. Pacira Liposomes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 84. Pacira Product
Table 85. Pacira Recent Development
Table 86. Sun Pharmaceutical Corporation Information
Table 87. Sun Pharmaceutical Description and Major Businesses
Table 88. Sun Pharmaceutical Liposomes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 89. Sun Pharmaceutical Product
Table 90. Sun Pharmaceutical Recent Development
Table 91. Luye Pharma Corporation Information
Table 92. Luye Pharma Description and Major Businesses
Table 93. Luye Pharma Liposomes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 94. Luye Pharma Product
Table 95. Luye Pharma Recent Development
Table 96. Sigma-Tau Group Corporation Information
Table 97. Sigma-Tau Group Description and Major Businesses
Table 98. Sigma-Tau Group Liposomes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 99. Sigma-Tau Group Product
Table 100. Sigma-Tau Group Recent Development
Table 101. Fudan-Zhangjiang Corporation Information
Table 102. Fudan-Zhangjiang Description and Major Businesses
Table 103. Fudan-Zhangjiang Liposomes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 104. Fudan-Zhangjiang Product
Table 105. Fudan-Zhangjiang Recent Development
Table 106. Teva Pharmaceutical Corporation Information
Table 107. Teva Pharmaceutical Description and Major Businesses
Table 108. Teva Pharmaceutical Liposomes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 109. Teva Pharmaceutical Product
Table 110. Teva Pharmaceutical Recent Development
Table 111. CSPC Corporation Information
Table 112. CSPC Description and Major Businesses
Table 113. CSPC Liposomes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 114. CSPC Product
Table 115. CSPC Recent Development
Table 116. Novartis Corporation Information
Table 117. Novartis Description and Major Businesses
Table 118. Novartis Liposomes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 119. Novartis Product
Table 120. Novartis Recent Development
Table 121. Kingond Pharm Corporation Information
Table 122. Kingond Pharm Description and Major Businesses
Table 123. Kingond Pharm Liposomes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 124. Kingond Pharm Product
Table 125. Kingond Pharm Recent Development
Table 126. Spectrum Pharmaceuticals Corporation Information
Table 127. Spectrum Pharmaceuticals Description and Major Businesses
Table 128. Spectrum Pharmaceuticals Liposomes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 129. Spectrum Pharmaceuticals Product
Table 130. Spectrum Pharmaceuticals Recent Development
Table 131. Shanghai New Asia Corporation Information
Table 132. Shanghai New Asia Description and Major Businesses
Table 133. Shanghai New Asia Liposomes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 134. Shanghai New Asia Product
Table 135. Shanghai New Asia Recent Development
Table 136. Global Liposomes Sales Forecast by Regions (2021-2026) (K Units)
Table 137. Global Liposomes Sales Market Share Forecast by Regions (2021-2026)
Table 138. Global Liposomes Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 139. Global Liposomes Revenue Market Share Forecast by Regions (2021-2026)
Table 140. North America: Liposomes Sales Forecast by Country (2021-2026) (K Units)
Table 141. North America: Liposomes Revenue Forecast by Country (2021-2026) (US$ Million)
Table 142. Europe: Liposomes Sales Forecast by Country (2021-2026) (K Units)
Table 143. Europe: Liposomes Revenue Forecast by Country (2021-2026) (US$ Million)
Table 144. Asia Pacific: Liposomes Sales Forecast by Region (2021-2026) (K Units)
Table 145. Asia Pacific: Liposomes Revenue Forecast by Region (2021-2026) (US$ Million)
Table 146. Latin America: Liposomes Sales Forecast by Country (2021-2026) (K Units)
Table 147. Latin America: Liposomes Revenue Forecast by Country (2021-2026) (US$ Million)
Table 148. Middle East and Africa: Liposomes Sales Forecast by Country (2021-2026) (K Units)
Table 149. Middle East and Africa: Liposomes Revenue Forecast by Country (2021-2026) (US$ Million)
Table 150. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 151. Key Challenges
Table 152. Market Risks
Table 153. Main Points Interviewed from Key Liposomes Players
Table 154. Liposomes Customers List
Table 155. Liposomes Distributors List
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Liposomes Product Picture
Figure 2. Global Liposomes Sales Market Share by Type in 2020 & 2026
Figure 3. Liposomal Doxorubicin Product Picture
Figure 4. Liposomal Amphoteracin B Product Picture
Figure 5. Liposomal Paclitaxel Product Picture
Figure 6. Other Product Picture
Figure 7. Global Liposomes Sales Market Share by Application in 2020 & 2026
Figure 8. Fungal Infection Therapy
Figure 9. Cancer & Tumor Therapy
Figure 10. Other
Figure 11. Liposomes Report Years Considered
Figure 12. Global Liposomes Market Size 2015-2026 (US$ Million)
Figure 13. Global Liposomes Sales 2015-2026 (K Units)
Figure 14. Global Liposomes Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Liposomes Sales Market Share by Region (2015-2020)
Figure 16. Global Liposomes Sales Market Share by Region in 2019
Figure 17. Global Liposomes Revenue Market Share by Region (2015-2020)
Figure 18. Global Liposomes Revenue Market Share by Region in 2019
Figure 19. Global Liposomes Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Liposomes Revenue in 2019
Figure 21. Liposomes Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Liposomes Sales Market Share by Type (2015-2020)
Figure 23. Global Liposomes Sales Market Share by Type in 2019
Figure 24. Global Liposomes Revenue Market Share by Type (2015-2020)
Figure 25. Global Liposomes Revenue Market Share by Type in 2019
Figure 26. Global Liposomes Market Share by Price Range (2015-2020)
Figure 27. Global Liposomes Sales Market Share by Application (2015-2020)
Figure 28. Global Liposomes Sales Market Share by Application in 2019
Figure 29. Global Liposomes Revenue Market Share by Application (2015-2020)
Figure 30. Global Liposomes Revenue Market Share by Application in 2019
Figure 31. North America Liposomes Sales Growth Rate 2015-2020 (K Units)
Figure 32. North America Liposomes Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Liposomes Sales Market Share by Country in 2019
Figure 34. North America Liposomes Revenue Market Share by Country in 2019
Figure 35. U.S. Liposomes Sales Growth Rate (2015-2020) (K Units)
Figure 36. U.S. Liposomes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Liposomes Sales Growth Rate (2015-2020) (K Units)
Figure 38. Canada Liposomes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Liposomes Market Share by Type in 2019
Figure 40. North America Liposomes Market Share by Application in 2019
Figure 41. Europe Liposomes Sales Growth Rate 2015-2020 (K Units)
Figure 42. Europe Liposomes Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Liposomes Sales Market Share by Country in 2019
Figure 44. Europe Liposomes Revenue Market Share by Country in 2019
Figure 45. Germany Liposomes Sales Growth Rate (2015-2020) (K Units)
Figure 46. Germany Liposomes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Liposomes Sales Growth Rate (2015-2020) (K Units)
Figure 48. France Liposomes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Liposomes Sales Growth Rate (2015-2020) (K Units)
Figure 50. U.K. Liposomes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Liposomes Sales Growth Rate (2015-2020) (K Units)
Figure 52. Italy Liposomes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Liposomes Sales Growth Rate (2015-2020) (K Units)
Figure 54. Russia Liposomes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Liposomes Market Share by Type in 2019
Figure 56. Europe Liposomes Market Share by Application in 2019
Figure 57. Asia Pacific Liposomes Sales Growth Rate 2015-2020 (K Units)
Figure 58. Asia Pacific Liposomes Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Liposomes Sales Market Share by Region in 2019
Figure 60. Asia Pacific Liposomes Revenue Market Share by Region in 2019
Figure 61. China Liposomes Sales Growth Rate (2015-2020) (K Units)
Figure 62. China Liposomes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Liposomes Sales Growth Rate (2015-2020) (K Units)
Figure 64. Japan Liposomes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Liposomes Sales Growth Rate (2015-2020) (K Units)
Figure 66. South Korea Liposomes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Liposomes Sales Growth Rate (2015-2020) (K Units)
Figure 68. India Liposomes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Liposomes Sales Growth Rate (2015-2020) (K Units)
Figure 70. Australia Liposomes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Liposomes Sales Growth Rate (2015-2020) (K Units)
Figure 72. Taiwan Liposomes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Liposomes Sales Growth Rate (2015-2020) (K Units)
Figure 74. Indonesia Liposomes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Liposomes Sales Growth Rate (2015-2020) (K Units)
Figure 76. Thailand Liposomes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Liposomes Sales Growth Rate (2015-2020) (K Units)
Figure 78. Malaysia Liposomes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Liposomes Sales Growth Rate (2015-2020) (K Units)
Figure 80. Philippines Liposomes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Liposomes Sales Growth Rate (2015-2020) (K Units)
Figure 82. Vietnam Liposomes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Liposomes Market Share by Type in 2019
Figure 84. Asia Pacific Liposomes Market Share by Application in 2019
Figure 85. Latin America Liposomes Sales Growth Rate 2015-2020 (K Units)
Figure 86. Latin America Liposomes Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Liposomes Sales Market Share by Country in 2019
Figure 88. Latin America Liposomes Revenue Market Share by Country in 2019
Figure 89. Mexico Liposomes Sales Growth Rate (2015-2020) (K Units)
Figure 90. Mexico Liposomes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Liposomes Sales Growth Rate (2015-2020) (K Units)
Figure 92. Brazil Liposomes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Liposomes Sales Growth Rate (2015-2020) (K Units)
Figure 94. Argentina Liposomes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Liposomes Market Share by Type in 2019
Figure 96. Latin America Liposomes Market Share by Application in 2019
Figure 97. Middle East and Africa Liposomes Sales Growth Rate 2015-2020 (K Units)
Figure 98. Middle East and Africa Liposomes Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Liposomes Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Liposomes Revenue Market Share by Country in 2019
Figure 101. Turkey Liposomes Sales Growth Rate (2015-2020) (K Units)
Figure 102. Turkey Liposomes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Liposomes Sales Growth Rate (2015-2020) (K Units)
Figure 104. Saudi Arabia Liposomes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Liposomes Sales Growth Rate (2015-2020) (K Units)
Figure 106. U.A.E Liposomes Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Liposomes Market Share by Type in 2019
Figure 108. Middle East and Africa Liposomes Market Share by Application in 2019
Figure 109. North America Liposomes Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 110. North America Liposomes Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Liposomes Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. Europe Liposomes Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Liposomes Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Asia Pacific Liposomes Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Liposomes Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Latin America Liposomes Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Liposomes Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 118. Middle East and Africa Liposomes Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
部位特異的ドラッグデリバリーの世界市場（～2026年） The selective delivery of chemotherapeutic agents to their site of action should increase therapeutic effectiveness and limit side effects. Most drug therapies currently available, however, exhibit little, if any specificity. Many times, a drug has limited or no access to its intended site of action…- 真菌感染症診断の世界市場（～2026年） ASSOCIATES OF CAPE COD, BioRad, IMMY and other leading products occupy a leading position in the international market, with a total market share OF about 80% in the global market. Among them, Jinshanchuan, Danna Biological and Zhanjiang A & C Biological are domestic production enterprises in China, …
- 卵巣がん遺伝子治療の世界市場（～2026年） Ovarian cancer occurs and arises from several types of cells within the ovary, and it has the lowest survival rate of all gynecological cancers. Among many types, epithelial ovarian cancer (EOC) is the most common ovarian cancer, whereas ovarian low malignant potential tumor (OLMPT), germ cell tumor…
- がん幹細胞治療の世界市場（～2026年） Market Analysis and Insights: Global Cancer Stem Cell Therapy Market The global Cancer Stem Cell Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Cancer Stem Cell Therapy Scope and Market Size Cancer Stem Cell T…
- 膵臓がん治療の世界市場（～2026年） Pancreatic cancer therapy is recommended by clinicians for early detection of cancer. Pancreatic cancer generally diagnosed at a later stage, since the symptoms are not easily detected or diagnosed. Factors such as, chronic inflammation of the pancreas (pancreatitis), diabetes, smoking, and obesity …